Please assess the completion status of the following clinical trial:

Trial Title: Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients underwent ESD for gastric adenoma or cancer~Exclusion Criteria:~* subjects with previous gastric surgery~* subjects taking aspirin, anticoagulant, or antiplatelet agent~* subjects having malignancy except gastric cancer~* pregnant or breast-feeding women

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pantoprazole (Type: OTHER): controls Pantoprazole 40mg qd for 28days
- Pantoprazole + Rebamipde (Type: ACTIVE_COMPARATOR): Pantoprazole 40mg qd + Rebamipide 100mg Tid for 28days

Based on this trial design, predict the completion outcome and termination type (if applicable).